Palvella Therapeutics Inc... (PVLA)
NASDAQ: PVLA
· Real-Time Price · USD
23.51
-1.54 (-6.15%)
At close: Jun 16, 2025, 3:59 PM
24.59
4.59%
Pre-market: Jun 17, 2025, 08:29 AM EDT
-6.15% (1D)
| Bid | 17.69 |
| Market Cap | 259.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.25M |
| EPS (ttm) | -2.08 |
| PE Ratio (ttm) | -11.3 |
| Forward PE | -7.82 |
| Analyst | Buy |
| Ask | 26.66 |
| Volume | 41,262 |
| Avg. Volume (20D) | 84,977 |
| Open | 25.50 |
| Previous Close | 25.05 |
| Day's Range | 23.40 - 25.50 |
| 52-Week Range | 6.20 - 29.27 |
| Beta | -0.10 |
About PVLA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PVLA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PVLA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-15.72%
Palvella Therapeutics shares are trading lower on ...
Unlock content with
Pro Subscription
4 months ago
+6.26%
Palvella Therapeutics shares are trading higher after TD Cowen initiated coverage on the stock with a Buy rating and announced a price target of $44.